GlassScriptPhysician profile
Brenda Cacucci
NPI 1134165541
$2,993.51
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $2,310 · 2021: $16.25.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $1,967.50 | 2019-2020 | |
| Novo Nordisk INC | $322.23 | 2019-2020 | |
| Intuitive Surgical, INC. | $278.43 | 2019-2020 | |
| Abbvie INC. | $188.38 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $121.80 | 2019-2020 | |
| Tela Bio, INC. | $61.16 | 2019 | |
| Shire North American Group INC | $25.14 | 2019 | |
| Nestle Healthcare Nutrition INC. | $16.25 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Cacucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.